Graves orbitopathy, also known as thyroid eye disease or thyroid-associated orbitopathy, is
visually disabling, cosmetically disfiguring and has a substantial negative impact on a …

Graves’ Disease | New England Journal of Medicine Skip to main content The New England
Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …

Graves' orbitopathy (GO) is the main extrathyroidal manifestation of Graves' disease (GD).
Choice of treatment should be based on the assessment of clinical activity and severity of …

Graves' orbitopathy (GO) is the main extrathyroidal manifestation of Graves' disease, though
severe forms are rare. Management of GO is often suboptimal, largely because available …

Methods European Group on GO (EUGOGO) represents a multidisciplinary consortium of
clinicians from the European centers, who share a commitment to improving the …

abstract Context: The administration of iv glucocorticoid pulses has been advocated as a
treatment approach for patients with inflammatory and moderate to severe Graves' …

Graves' orbitopathy (GO) constitutes a major clinical and therapeutic challenge (1, 2). GO is
an autoimmune disorder representing the commonest and most important extrathyroidal …

Abstract Introduction Graves' orbitopathy (GO), thyroid dermopathy (also called pretibial
myxedema) and acropachy are the extrathyroidal manifestations of Graves' disease. They …

Context: Glucocorticoids are effective for severe Graves' orbitopathy (GO), which causes
substantial morbidity. The question at issue is how best to use them. Objective: The objective …

Graves' disease (GD) is an autoimmune disease that primarily affects the thyroid gland. It is
the most common cause of hyperthyroidism and occurs at all ages but especially in women …